Knowledge and Attitudes Concerning Aducanumab Among Older Americans After FDA Approval for Treatment of Alzheimer Disease.

ABSTRACT:

SUBMITTER: Zissimopoulos J 

PROVIDER: S-EPMC8845005 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature